Literature DB >> 3795347

Demonstration of residual contrast medium in renal parenchyma using computerized tomography.

H U Braedel, E Schindler, P Cullen, E Hoene.   

Abstract

Residual contrast medium in the renal parenchyma was demonstrated by computerized tomography in 11 patients with renal trauma, inflammatory renal disease, infarction and a large renal cyst. The contrast medium (10 to 100 ml.) was administered intravascularly 30 minutes to 48 hours before the computerized tomography scan. In each patient the scan demonstrated residual contrast medium (either initially or after a second scan with additional contrast enhancement) in a variety of parenchymal zones that frequently appear to be normal with other imaging techniques. After a suitable interval for accumulation of residual contrast medium, computerized tomography appears to provide better visualization of the renal parenchyma than conventional modes of examination. Persistent retention of contrast medium in the renal parenchyma is believed to represent cortical damage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3795347     DOI: 10.1016/s0022-5347(17)43856-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Perinephric inflammatory process following extracorporeal shock wave lithotripsy.

Authors:  J Peiser; J Kaneti; L Lissmer; J Klain; C Blank; Y Hertzanu
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

2.  Persistent CT nephrograms following cardiac catheterisation and intervention: initial observations.

Authors:  Richard W Katzberg; Wayne L Monsky; Nicolas D Prionas; Vishal Sidhar; Jeffrey Southard; Janine Carlson; John M Boone; Tzu-Chun Lin; Chin-Shang Li
Journal:  Insights Imaging       Date:  2011-11-16

3.  Clinical factors associated with dense and wedge-shaped nephrograms detected 24 h after chemoembolization.

Authors:  Wayne L Monsky; Anokh Pahwa; Chin-Shang Li; Richard W Katzberg
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.